Autonomix enrolls first patients in human clinical trial targeting multi-billion-dollar pancreatic cancer market

First trial to ever evaluate radiofrequency (rf) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer

AMIX Ratings Summary

AMIX Quant Ranking